University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 9 of 15
Effect of Inhaled Albuterol in Pulmonary Hypertension
NCT03270332
Mindfulness Training in Military Spouses
NCT03308344
INR Comparison Testing in Cardiac Surgery
NCT03267823
Exercise, Cognitive Function and Neuroplasticity in Healthy Adults
NCT02994134
Compassion Cultivation Training for Nurses
NCT03286192
CROS Application in CI
NCT03243097
TENS Trial to Prevent Neuropathic Pain in SCI
NCT03267810
Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)
NCT03028324
Investigating Train the Trainer Delivery of Mindfulness-based Training
NCT03250156
Teacher Child Interaction Training (TCIT): Randomized Control Trial
NCT04000230
Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome
NCT02681666
Inspiratory Muscle Training Post-Liver Transplant
NCT03130608
Efficacy of Suction Enabled Retraction Device
NCT03160170
Assessing the Stability of Transcranial Magnetic Stimulation Plasticity Responses
NCT03034629
Family Automated Voice Reorientation Study
NCT03128671
Hematopoetic Stem Cell Transplant and Physical Function
NCT03103308
Use of RM Technology in Pediatric BAI Recipients
NCT03149484
AchE Inhibitor and Insulin
NCT03063515
eHealth Evidence-based Intervention (EBI) for Latino Youth in Primary Care
NCT03009539
3D Rotational CT Angiogram With Embolization Guidance and CBCT in Prostatic Artery Embolization
NCT03164629
Synergistic Effect of Vedolizumab and Pentoxifylline
NCT02953275
Smoking Cessation in Hispanic Construction Workers
NCT02873377
Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
NCT02658084
Super Power in BAI
NCT03118375
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
NCT02970136
Behavioral Manifestations of Listening Effort
NCT03087045
Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS)
NCT02743520
Fun For Wellness: Online Well-Being Promotion Intervention in a Patient Sample
NCT03060213
Safety and Efficacy of Low Intensity Shockwave for the Treatment of Erectile Dysfunction
NCT03067987
Evaluation of Acute and Subacute Effects of Nicotine Free Electronic Cigarette(NCFE) Vapors
NCT02585791
Parkinson's Autonomic Responses to Treadmill Walking
NCT03156400
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
NCT03012932
Translational Health After School Program on Health-Related Knowledge/Behaviors and Exercise Perception
NCT02932813
Clinical Power Testing Across Human Lifetime
NCT03160963
Proprioception and Meditation
NCT03079817
Unified Protocol for Adolescents (UP-A) Change Processes
NCT03102008
Trauma Intervention for Affect Regulation, AIDS, and Substances
NCT02923141
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
NCT02834975
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
NCT02737046
Vortioxetine for Posttraumatic Stress Disorder
NCT02637895
Effects of Intermittent Hypoxia (IH) on Metabolism and Dysglycemia, in Overweight/Obese Persons SCI
NCT02973438
Clinical Outcomes of ACL Reconstruction Augmented by an Injectable Osteoconductive/Osteoinductive Compound
NCT04993339
Web-based Programs to Improve and Strengthen Romantic Relationships
NCT02806635
The Hemophilia Ultrasound Project
NCT02807753
Biomechanics of Optic Neuropathy
NCT02982499
Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
NCT02834988
Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?
NCT02701764
VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer)
NCT03955991
Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South Africa
NCT02696824
A Lifestyle Intervention Targeting Enhanced Health and Function for Persons With Chronic SCI in Caregiver/Care-Receiver Relationships: Effects of Caregiver Co-Treatment
NCT02853149
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Miami pipeline card: 721 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.